Analysts mostly agreed that the Wegovy pill's approval was a big deal, even though many had already expected a positive decision before the end of the year
They are comparable to any clinic around
The documented benefits extend beyond theoretical longevity: improved sleep quality and circadian rhythm regulation through pineal gland support, enhanced immune function markers, normalized melatonin production in aging individuals, reduced oxidative stress, improved skin elasticity and appearance, and potential disease prevention through cellular optimization
As of March 2026, just 13 state Medicaid programs cover GLP-1 medications, including Ozempic, for obesity treatment: Delaware Kansas Massachusetts Michigan Minnesota Mississippi Missouri North Carolina Rhode Island Tennessee Utah Virginia Wisconsin Medicaid programs in California, New Hampshire, Pennsylvania, and South Carolina all recently ended obesity drug coverage, citing the steep cost of these medications